Stocks and Investing
Stocks and Investing
Fri, December 8, 2023
[ Fri, Dec 08th 2023
] - WOPRAI
[ Fri, Dec 08th 2023
] - WOPRAI
[ Fri, Dec 08th 2023
] - WOPRAI
[ Fri, Dec 08th 2023
] - WOPRAI
[ Fri, Dec 08th 2023
] - WOPRAI
[ Fri, Dec 08th 2023
] - WOPRAI
[ Fri, Dec 08th 2023
] - WOPRAI
[ Fri, Dec 08th 2023
] - WOPRAI
[ Fri, Dec 08th 2023
] - WOPRAI
[ Fri, Dec 08th 2023
] - WOPRAI
[ Fri, Dec 08th 2023
] - WOPRAI
[ Fri, Dec 08th 2023
] - WOPRAI
[ Fri, Dec 08th 2023
] - WOPRAI
[ Fri, Dec 08th 2023
] - WOPRAI
Thu, December 7, 2023
[ Thu, Dec 07th 2023
] - WOPRAI
[ Thu, Dec 07th 2023
] - WOPRAI
[ Thu, Dec 07th 2023
] - WOPRAI
[ Thu, Dec 07th 2023
] - WOPRAI
[ Thu, Dec 07th 2023
] - WOPRAI
[ Thu, Dec 07th 2023
] - WOPRAI
[ Thu, Dec 07th 2023
] - WOPRAI
[ Thu, Dec 07th 2023
] - WOPRAI
[ Thu, Dec 07th 2023
] - WOPRAI
[ Thu, Dec 07th 2023
] - WOPRAI
[ Thu, Dec 07th 2023
] - WOPRAI
[ Thu, Dec 07th 2023
] - WOPRAI
Danielle Brill Upgraded (BIIB) to Buy and Held Target at $283 on, Dec 7th, 2023
Danielle Brill of Raymond James, Upgraded "Biogen Inc." (BIIB) to Buy and Held Target at $283 on, Dec 7th, 2023.
Danielle has made no other calls on BIIB in the last 4 months.
There are 12 other peers that have a rating on BIIB. Out of the 12 peers that are also analyzing BIIB, 3 agree with Danielle's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Laura Chico of "Wedbush" Maintained at Hold with Decreased Target to $239 on, Thursday, November 9th, 2023
- Steve Chesney of "Atlantic Equities" Maintained at Hold with Decreased Target to $275 on, Tuesday, August 8th, 2023
- Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $294 on, Tuesday, August 8th, 2023
These are the ratings of the 9 analyists that currently disagree with Danielle
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $373 on, Friday, November 10th, 2023
- Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $365 on, Thursday, November 9th, 2023
- Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $363 on, Thursday, November 9th, 2023
- Evan Seigerman of "BMO Capital" Maintained at Buy with Decreased Target to $295 on, Thursday, November 9th, 2023
- Ami Fadia of "Needham" Reiterated at Strong Buy and Held Target at $305 on, Thursday, October 26th, 2023
- Morten Herholdt of "HSBC" Initiated at Strong Buy and Held Target at $360 on, Wednesday, September 6th, 2023
- Salim Syed of "Mizuho" Maintained at Strong Buy with Decreased Target to $335 on, Monday, August 14th, 2023
- Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Decreased Target to $340 on, Tuesday, August 8th, 2023
- Jay Olson of "Oppenheimer" Maintained at Buy with Decreased Target to $290 on, Monday, August 7th, 2023
Contributing Sources